HomeORX • STO
add
Orexo AB
Nakaraang pagsara
kr 14.40
Sakop ng araw
kr 14.12 - kr 14.98
Sakop ng taon
kr 9.18 - kr 24.00
Market cap
500.53M SEK
Average na Volume
17.05K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 160.30M | -3.43% |
Gastos sa pagpapatakbo | 148.90M | 3.84% |
Net na kita | -116.20M | -524.73% |
Net profit margin | -72.49 | -547.23% |
Kita sa bawat share | -3.37 | -524.07% |
EBITDA | 115.90M | 393.19% |
Aktuwal na % ng binabayarang buwis | -9.31% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 123.30M | -27.89% |
Kabuuang asset | 594.80M | -24.38% |
Kabuuang sagutin | 721.10M | -0.91% |
Kabuuang equity | -126.30M | — |
Natitirang share | 34.51M | — |
Presyo para makapag-book | -3.93 | — |
Return on assets | -4.22% | — |
Return on capital | -6.80% | — |
Cash Flow
Net change in cash
| (SEK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -116.20M | -524.73% |
Cash mula sa mga operasyon | 6.20M | 338.46% |
Cash mula sa pag-invest | -800.00K | 11.11% |
Cash mula sa financing | -4.90M | 10.91% |
Net change in cash | 8.40M | 163.64% |
Malayang cash flow | 77.54M | 690.19% |
Tungkol
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Itinatag
1995
Website
Mga Empleyado
110
